Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 6.37 M6.81 M15.23 M-2.9 M5.96 M7.09 M 25.37 M Research & development —————— — Operating income -19.5 M16.99 M10.09 M27.99 M20.06 M21.3 M 79.44 M Non-Operating Income, Total -618 K211 K279 K69 K272 K380 K 1 M Interest expense, net of interest capitalized 11.88 M11.27 M10.49 M10.55 M9.66 M9.3 M 40.01 M Non-Operating Income, excl. Interest Expenses -12.5 M-11.06 M-10.21 M-10.48 M-9.39 M-8.92 M -39.01 M Unusual income/expense —————— — Pretax income -16.51 M5.03 M-1.95 M7.75 M8.19 M9.47 M 23.46 M Equity in earnings —————— — Taxes -4.92 M1.16 M-1.04 M2.41 M2.19 M2.3 M 5.86 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -11.59 M3.87 M-907 K5.33 M6 M7.17 M 17.59 M Discontinued operations —————— — Net income -11.59 M3.87 M-907 K5.33 M6 M7.17 M 17.59 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -11.59 M3.87 M-907 K5.33 M6 M7.17 M 17.59 M Basic earnings per share (Basic EPS) ——-0.050.290.320.39 0.95 Diluted earnings per share (Diluted EPS) ——-0.050.290.320.39 0.95 Average basic shares outstanding ——18.52 M18.53 M18.56 M18.58 M — Diluted shares outstanding ——18.52 M18.53 M18.56 M18.58 M — EBITDA -31.64 M4.96 M-1.44 M15.9 M9.69 M10.81 M 34.96 M EBIT -31.65 M5 M-1.36 M16.03 M9.87 M11.08 M 35.62 M Cost of revenue 17.62 M1.07 M1.54 M1.22 M1.09 M892 K 4.74 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 14 K-45 K-80 K-130 K-176 K-274 K -660 K